CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

February 24, 2022 · earnings

NTLA earnings: a positive outcome, +9.3%

On February 24, 2022, Intellia Therapeutics, Inc. reached its earnings. The result was a positive outcome, and the stock moved +9.3% in the window around the event.

The move

$80.05
1d before
$87.46
Event day
$96.36
1d after
$79.85
5d after

Pre-catalyst setup

+2.1%
30-day run-up
7297%
30-day volatility
1.1×
volume spike